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ABSTRACT

Author: Sortedahl, Nicholas, J. Ph.D.
Institution: Purdue University
Degree Received: December 2017
Title: Epoxide Bonded Phases for Chromatography and Immunoprecipitation
Major Professor: Dr. Mary Wirth
Biomarker discovery is a difficult process. The goal of this work is to improve
upon current state-of-the-art separation and extraction technology using functional
epoxide surfaces. Specific attention is paid to immunoprecipitation and DNA separations.
Immunoprecipitation is an excellent option when clean protein capture is
required. Magnetic particles allow these experiments to be conducted in a high throughput fashion necessary for biomarker validation studies. However, commercial magnetic
immunoprecipitation particles suffer from low particle magnetization, low capacity, and
high nonspecific binding. By designing a new acid stable silica coated magnetic particle
(Fe3O4@SiO2) a two-fold increase in signal to nose, and almost three-fold increase in
magnetization was observed over commercial magnetic particles.
Recent advances in protein engineering has opened the door for new analytical
techniques. With the discovery of transcription activator like effectors (TALE) protein
specific DNA sequences can now be targeted. Development of a TALE chromatography
column allowed the first ever separation of double stranded DNA via sequence
recognition. This proof of concept work could allow a different method by which to study
proteins that interact with double stranded DNA. The advantage of this method over a
standard chromatin immunoprecipitation (ChIP) assay is that a specific sequence can be

xii
chosen without the need to transfect cells. Direct purification of specific DNA sequences
would be possible without the need to transfect cells.
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CHAPTER 1.

1.1

INTRODUCTION

Biomarker Analysis from Serum using PSA as a Case Study
Serum proteins present a gold mine of biological information. Almost 3700 unique

proteins have been observed in human serum samples. 1,2 If one considers even a small
subset of post-translational modifications (PTM’s), such as glycosylation, the vastness of
chemical information becomes apparent.3 The advantage of studying serum is that the
circulatory system is in intimate contact with all bodily tissues. This allows sampling of
tissues deep within the body by using relatively noninvasive blood tests. However, signal
to noise ratio becomes a significant problem. Specifically, the large volume of blood and
small volume of a potential tumor makes detecting and quantifying cancer biomarkers
difficult.
One example of a well-studied biomarker is prostate specific antigen (PSA).
Stamey et al. analyzed 699 serum samples in 1987 which showed excellent correlation
between prostate tumor size and PSA levels in the blood.4 However, it is estimated that
quantifying PSA alone can lead to an over diagnosis of prostate cancer somewhere
between 23% and 42%.5 Due to the extreme nature of prostate cancer treatment, it is
imperative to develop a more accurate method for determining the presence of prostate
cancer.
Quantifying PSA glycosylation levels has shown promise. The ratio between α2,3linked sialic acid and core fucosylation has been shown to be a better predictor of
prostate cancer than total PSA levels alone.6 Although this new analysis method holds
promise, it relies on multiple steps such as an immunoprecipitation, lectin arrays, lectin
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chromatography, and gel electrophoresis. All of which lead to an analysis time of over
three days. As such this method is not amenable to routine clinical analysis or high
throughput biomarker discovery and validation. Using PSA as a guide, future biomarker
analysis techniques should be able to analyze all PTM’s at ng/ml from serum samples.

1.2

Considerations in Immunochemistry
Immunoassay was first proven to be a viable analytical tool in 1959 when it was

used to detected insulin at clinically relevant concentrations.7 Further improvements in
detection, and antibody surface conjugation lead to the development of the enzymelinked immunosorbent assay (ELISA) in 1971.8 Although nearly 60 years have passed
since immunochemistry first proved to be clinically relevant, the basic principles are still
the same. Antibodies are used to selectively enrich a target of interest. The target is then
detected via an enzymatic reaction, LC-MS, or other analytical method. Figure 1.1
describes the basic workflow. Although immunoassays have been developed for many
different antigens the antigen antibody binding constant (Kb) plays a major role in the
performance of any immunoassay. Equation 1 describes the equilibrium constant. The
terms are defined as; bound antibody/antigen complex [AbAg], free antibody [Ab], and
free antigen [Ag]:
(1)
Kb values as high as 1011 have been reported, but generally 106 to 109 are common.9 The
strong binding affinity, and high selectivity of antibodies allows specific targets to be
extracted and purified using immunochemistry.
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1.3

Magnetic Immunoprecipitation Particle Design
Attaining low limits of detection for analytes in serum is difficult. To improve

detection limits and signal to noise immunoprecipitation is commonly used. However,
any assays developed must have high sample throughput. This is usually attained through
the use of magnetic particles which easily integrate into the 96 well plates format.
Magnetic particles also improve signal to noise when used with the appropriate
technique.10 Different design strategies have been implemented to improve
immunochemistry performance of magnetic particles. They can roughly be broken down
into three categories; particle design, surface morphology, and binding chemistry.
Due to the poor surface chemistry of Fe3O4, and iron’s propensity to oxidase
proteins, Fe3O4 is generally coated with polymer or silica.11–13 Two particle designs are
possible and are outlined in Figure 1.2. The most common particle design is the “plum
pudding” model as it allows Fe3O4 nanoparticles to be small enough to enter the
superparamagnetic regime, where the particles are not magnetically attracted to on
another, but a total particle size and magnetic force large enough to allow for a speedy
recovery. If superparamagnetism is not required larger ferromagnetic particles can be
used which allows overall size of the magnetic particle to decrease while still maintaining
high particle magnetization. For example, single 100-nm Fe3O4 particles can be extracted
from solution using a N52 neodymium magnet.14 Conversely superparamagnetic
Dynabeads must be at least 1.0 µm in size for a reasonable extraction rate to be
attained.12 The difficulty in working with ferromagnetic particles is that, on top of
intermolecular forces drawing the particles together, magnetic forces are also present,
decreasing colloidal stability and causing aggregation during surface modification steps.
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Two groups have demonstrated that repulsive forces based on charge interactions are
sufficient to overcome the attractive forces.15,17
Limitations in making particle size smaller for higher surface area have lead some
manufacturers to develop porous surfaces of agarose. Although porous surfaces have high
surface area, they generally have poor antigen recovery as the high polydispersity of the
pores in the agarose matrix results in trapped antigen. Due to poor recovery, porous
surfaces are generally used for removing high concentration albumin which can interfere
with some analysis.18 If high recovery of the antigen is required then nonporous surfaces
are used as no small pores exist to trap antigen.
Determining the chemistry for attaching biomolecules to the particle surface is the
final step in particle design. Figure 1.3 outlines different linker surface chemistries
available. Each linker has its advantages and disadvantages but in general the lowest
biofouling linker is the epoxide. This is due to the surface not gaining charge when
coupling reactions are performed or when the epoxide ring opens due to hydrolysis.
Functional groups such as N-hydroxysuccimide esters, can generate a surface charge
when hydrolyzed to a carboxylic acid increasing nonspecific binding. Other surface, s
such as amines, can be used; however, they require activation using 1-ethyl-3-(3dimethylaminopropyl)carbodiimide for binding, and any unreacted groups leave a
residual surface charge.

1.4

Surface Initiated AGET ATRP of Glycidyl Methacrylate
Independently developed by Sawamoto, Wang, and Matyjaszewski, atom transfer

radical polymerization (ATRP) allows radical polymerization to be performed using
living polymerization methods.19,20 Excellent control over chain length, polydispersity,
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and chain ends can be attained. However, ATRP requires a deoxygenated environment.
To increase reaction robustness and reduce catalyst concentration activator generated by
electron transfer (AGET) was developed. AGET initiates ATRP by reducing the catalyst
complex to the active species via an air stable reducing agent. This reduces the need for a
completely oxygen free environment.21
Surface modification using ATRP has proven to be a robust method of growing
dense polymer layers on surfaces. Applications ranging from chromatographic bonded
phases to low biofouling surfaces have been shown.22,23 The introduction of surface
initiated (SI) AGET ATRP provides an even easier way to modify surfaces. In some
cases, this eliminates the need for oxygen removal.24
Glycidyl methacrylate represents a versatile monomer. Containing both a vinyl
and epoxide group, this monomer has been exploited to produce epoxide functionalized
surfaces which can bind antibodies, proteins, and peptides.25 However, AGET ATRP of
glycidyl methacrylate is not straightforward.
Common ATRP ligands all contain nucleophilic nitrogen groups that can react with
the epoxide ring, destroying the catalyst complex. To overcome this limitation, a bulky
chelating ligand can be used to drive the reaction to completion. Ligands such as tris(2(dimethylamino)ethyl)amine (Me6Tren) are active for approximately one hour when used
for the polymerization of glycidyl methacrylate, whereas the bulkier tris(2pyridylmethyl)amine (TPMA) can stay active for at least six hours. Epoxides are also
reducing agents, which makes reaction control difficult as copper II chloride can be
reduced to copper I chloride.26 Other techniques for gaining control of the reaction
involve lowering the concentration of glycidyl methacrylate. This slows the rate of the
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copper II to copper I reduction and allows the reaction to be controlled via the ATRP
mechanism.27,28
Polymerization of glycidyl methacrylate is an important step to synthesizing
functional surfaces. Controlling the reaction is difficult using the ATRP system as side
reactions between the monomer and catalyst complex disrupt original reaction
concentrations, slowing or stopping the reaction. These issues can be avoided if reaction
time is kept short or strong chelating ligands are used.

1.5

Histone Analysis and ChIP
Histone modification plays an important role in cancer and epigenetics.29,30

Chromatin immunoprecipitation, also known as ChIP is the common technique used to
determine histone modifications.31 Figure 1.4 describes the basic structure of the DNA
histone complex while Figure 1.5 describes the basic workflow of histone recognition
and analysis in ChIP. In short, chromatin is sheared into shorter 300-700 base pair lengths
via sonication. The histone of interest is immunoprecipitated, and the histone DNA
complex is denatured. The now free DNA is amplified and sequenced. Thus, the DNA
associated with the target protein can be studied.

1.6

Research Objective
Drug approval is an expensive undertaking. Analysis by Tufts estimated the cost to

bring one drug to market is upwards of 2.5 billion dollars.32 In part the high cost is due to
the small number of drugs that prove effective. Estimates are 90% of oncological drugs
do not reach market as they are toxic or fail to show therapeutic benefits in clinical
trials.33 Improved biomarkers discovery techniques would speed up the arduous process
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of drug development as diseases pathways could be better understood before drug design
begins. Better biomarker analysis would also directly benefit patients as disease
progression or regression could be monitored allowing treatments to be modified if
necessary.
Chapter one discusses the background, and basics of technology used in the
following chapters. Chapter two discusses the synthesis of an ultra-acid stable
Fe3O4@SiO2 particle. Further surface modification is used to produce an
immunoprecipitation particle useful in high throughput extraction experiments. A
performance comparison is conducted with two other commercial immunoprecipitation
particles.
Presented in chapter three is progress towards a sequence specific DNA separation.
Investigation of TALE found that sequence selectivity was not adequate for extraction.
Capillary chromatography was developed leading to an increase in selectivity, but
excessively short column lifetimes limited utility. In chapter four future directions are
discussed. Specifically, a proof of concept design for handling precious samples, and
other DNA selective chemistries to overcome issues associated with TALE proteins.
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Figure 1.1 (A) depicts surface bound antibodies selectively extracting a target analyte from a complex serum. (B) The high binding
affinity of antibodies allows serum proteins to be washed away while the antigen is retained. (C) The purified antigen can then be
released for further analysis.
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Figure 1.2 (A) The plum pudding model on the left shows superparamagnetic particles
(black) imbedded in a silica or polystyrene sphere (cream). This is how BcMag or
Dynabeads are designed. (B) The core shell design generally uses a silica shell with
larger (100 nm) magnetic core is used.
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Figure 1.3 (A-C) Represents a coupling reaction between a protein and an epoxide, Nhydroxysuccinimide ester, or N-hydroxysulfosuccinimide ester respectively. (D-F)
represent hydrolysis products for the same functional groups.
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Figure 1.4 The red DNA strand (A) wraps around the histone octamer (C) which is held
in place by the linker histone denoted by the grey cylinder, (B) the blue strand is the Nterminus of the histone protein
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.

Figure 1.5 (A) Chromatin strands are sheared via sonication into smaller subunits
generally under 700 base pairs in length, (B) an antibody selective for the N-terminus
region selectively attaches to the histone of interest which is purified via
immunoprecipitation, (C) The entire histone antibody complex is denatured, (E) DNA is
amplified and sequenced.
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Table 1.1 Literature survey of monomers with low biofouling characteristics. All
biofouling measurements were performed via surface plasmon resonance after exposure
to 100% serum.

ug/m2
Adsorbed
<10

Monomer

Citation

30

90 + 75

31

<30

32

50 + 15

33

88 + 80

31

72 + 10

33

10 + 10

31

<3

33
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Table 1.1, continued

ug/m2
Adsorbed
25

Monomer

Citation

34

16

35

<3

36

<3

33

17+ 7

37
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CHAPTER 2.

2.1

MAGNETIC IMMUNOPRECIPITATION

Abstract
Magnetic beads are widely used for high-throughput immunoprecipitation (IP). The

most widely used magnetic beads, e.g., Dynabeads, are 2.7 µm polystyrene spheres
embedded with superparamagnetic Fe3O4 nanoparticles. Epoxide functional groups at the
polystyrene surface allow binding of antibodies. The idea tested in this work is whether
using larger ferromagnetic Fe3O4 particles, protected by a nanoscale silica shell, i.e.,
Fe3O4@SiO2, would give stronger magnetism, by virtue of a great percentage of Fe3O4,
and higher binding capacity, by virtue of smaller particle size. To this end, silica shells
were formed on Fe3O4 nanoparticles by the Stöber process. Vacuum annealing at 1050 oC
was found to make the shells impervious to a 12 hour exposure of concentrated
hydrochloric acid. Imaging by TEM revealed that the annealed shells were 50 nm in
thickness. TEM also showed that the nanoparticles agglomerated into nearly micrometer
sized aggregates, albeit with high surface area. For functionalizing the shell surface, a 10
nm polymer layer was grafted to a silane initiator on the silica surface by SI AGET
ATRP. The polymer layer was a block copolymer of polyacrylamide, to minimize
nonspecific protein adsorption, and glycidyl methacrylate, to covalently attach antibodies.
The resulting Fe3O4@SiO2@polymer particles easily dispersed in aqueous solution. The
particles were determined by a superconducting quantum interference device (SQUID) to
be approximately two times more magnetic than Dynabeads. The binding capacity,
determined by IP, showed that the Fe3O4@SiO2@polymer particles have twice the
binding capacity as the Dynabeads while retaining low nonspecific binding.
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2.2

Introduction
Development of new extraction techniques such as AirJump, where magnetic

particles are pulled through the air-water interface, highlight the unique advantages of
using magnetic extraction over conventional extraction techniques. Specifically these
techniques have demonstrating increased recovery, decreased background, and increased
throughput capability.1 However, they can only be performed with magnetic particles.
This highlights the inherent benefits of improving magnetic nanoparticles over other
methods.2–4 Fe3O4@SiO2 nanoparticles have gained attention due to their increased
stability, and excellent surface functionality over bare magnetic nanoparticles.5 One issue
with Fe3O4@SiO2 type particles is that the silica shell can greatly reduce magnetism
resulting in particles that require impractical field gradients for extraction from solution.6
To mitigate this issue, larger Fe3O4 particles can be used, yielding high magnetic moment
particles.7 Another issue with Fe3O4@SiO2 particles is that they cannot take full
advantage of the silica coating, due to the porous nature of the silica.8,9 Generating dense
surface coverage of silanes is difficult as it requires refluxing the silica in concentrated
nitric acid. Surface modification using chlorosilanes is also detrimental to the magnetic
core as they release hydrochloric acid upon attachment to the silica surface.10,11 Both of
these steps are necessary to generate densely modified surfaces required for low
biofouling.12,13 Adding a copolymer such as glycidyl methacrylate allows biomolecules to
be bound to the surface while retaining low fouling properties.14,15

20
2.3

2.3.1

Experimental

Materials
House deionized water was purified using a Milli-Q Gradient system to a final

resistivity of 18.2 mΩ. 50-100 nm, and 30 nm Fe3O4 was purchased from Nanostructured
& Amorphous Materials, Inc. 200-proof ethanol was acquired from Decon Laborotories.
Branched polyethylenimine (PEI, Mw ∼ 25,000 Mn 10,000), tetraethyl orthosilicate
(TEOS, 97%) CuCl2 (99.995%) tris(2-dimethylaminoethyl)amine (Me6Tren, 97%)
acrylamide (99%), glycidyl methacrylate (97%), 2-Amino-2-hydroxymethyl-1,3propanediol (tris, 99.9%), phosphate buffered saline (tablet), and nitric acid (68%), were
procured from Sigma Aldrich. ((Chloromethyl)phenylethyl dimethyl)lchlorosilane (98%)
was purchased from Gelest. Silica gel (60 Å) was ordered from Sorbtech. Bovine serum
album (BSA, Alexa Fluor® 555 or 488 conjugate) BSA antibody (Anti-BSA, 70-BC67,
Fitzgerald). Dynabeads M-270 epoxide, T-20 non-protein blocking buffer, toluene
(99.5%), (Thermo Fisher Scientific). BcMag epoxide (Bioclone inc.).

2.3.2

Silica Coating
A 5 mg/ml dispersion of Fe3O4 in ethanol was sonicated (Branson 3800) for 3

hours. Upon completion, the dispersion is magnetically extracted, and dried at 60 oC
under vacuum. 500 mg of the dried material is added to 100 ml of aqueous solution
containing 1 w/v % PEI, sonicated 8 hours, and collected via centrifugation. 250 mg of
the PEI coated Fe3O4 is placed in 250 ml water, sonicated for 10 min, 10 ml of TEOS,
100 ml of ethanol are added, and sonicated continued for 1 hour. The particles are
magnetically extracted, washed 3x with ethanol, and dried at 60 oC. 110 mg of the silica
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coated Fe3O4 was sonicated for 10 min in 400 ml ethanol and 80 ml water. 8.3 ml
NH4OH and 1.0 ml of TEOS is added. Sonication is continued for 1 hour, particles are
magnetically extracted, and dried.

2.3.3

Thermal Treatments
The silica coated Fe3O4 is placed in a vacuum oven, heated to 1050 oC at a rate of

8 oC/min. to anneal the silica, held for 10 min, and allowed to cool at 15 oC/min.

2.3.4

Silica Modification
After annealing, 500 mg of silica-coated Fe3O4 is placed in 10 ml of 37 % HCl for

1 hour and washed until a neutral pH is reached. Upon completion 250 ml of 1.0 M
HNO3 is added and the particles are vigorously refluxed for 24 hours without a stir bar.
Particles are washed five times with water and dried in a clean room temperature
vacuum. 500 mg is placed in 100 ml of dried toluene, and sonicated into suspension
under a nitrogen blanket. 2.0 ml of ((chloromethyl)phenylethyldimethyl)lchlorosilane is
added along with 100 µl of ethyl amine. The reaction is vigorously refluxed for 3 hours.
Upon completion, the particles were washed three times with toluene and dried at 60 oC.

2.3.5

Polymer Grafting
All solvents are deoxygenated via nitrogen sparging for 30 min. In a 50 ml

centrifuge tube 14.1 mg CuCl2 (0.105 mmol), 17.5 ml methanol, 28.1 μl Me6Tren (0.105
mmol), 947 mg acrylamide (13.3 mmol), and 50 mg of initiator modified nanoparticles
were sonicated into solution under sparging. Upon suspension 17.5 ml water, and 3.4 mg
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sodium ascorbate (0.017 mmol) was added. After 5 min 2000 μl glycidyl methacrylate
(14.6 mmol), and 10.4 mg sodium ascorbate (0.0525 mmol) was added, and sparging was
continued for 5 min. Upon completion, the black particles are magnetically extracted,
washed three times with water, and vacuum dried overnight.

2.3.6

Antibody Capacity
5 mg/ml of epoxide coated particles are allowed to react with, 0.1 mg/ml Anti-

BSA in PBS. Samples were placed on a shaker plate at 750 rpm and allowed to react for a
specified time. Upon completion, a 50 µl aliquot is removed and diluted with 400 μl of T20 blocking buffer to stop the antibody binding. The vials are then agitated for 1 hour.
Blocked beads are washed three times with PBS and agitated in 100 μl of 0.1mg/ml
fluorescently labeled BSA PBS solution for one hour. Particles are washed three times
with 20 mM tris buffer pH 8.2 and suspended in 20 μl of 2% SDS for 30 min. The
supernatant is removed and placed in a cuvette with tris buffer.

2.3.7

Nonspecific Binding
Approximately 3 mg of beads were suspended in 600 μl of T-20 blocking buffer

and allowed to react for 1 hour, washed three times with PBS, and placed in 100 μl of 40
mg/ml fluorescent BSA PBS solution. After agitation for 1 hour. Particles were washed
six times, vials were changed and washed four more times with 20 mM tris. Release and
analysis conditions are the same as before.
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2.3.8

Magnetic Characterization
Approximately 5 mg of material is loaded into a SQUID straw and a four-

quadrant scan is performed using an MPMS-3 at 27 oC. An identical scan using
gadolinium gallium garnet was used to correct for residual magnetic moment of the
instruments at zero magnetic field by linear regression.

2.3.9

Infrared Analysis
Dried KBr was added to the tested samples to obtain a 0.3 % mixture. After

grinding it to fine powder in an agate mortar, approximately 80 mg was pelletized in a
hydraulic press. IR spectrums were collected using a FT-IR spectrometer (Tensor 37,
Bruker Optik GMBH).
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2.4

2.4.1

Results and Discussion

Particle Design
For IP particles to be successful it is important that the particles have a high

magnetization for fast and quantitative extraction. Many assays are based on the amount
of analyte extracted and any beads lost will lower yields. To this end, commercial Fe3O4
magnetic particles were coated in silica using the procedure outlined in section 2.3.2.

2.4.2

Synthesis Overview
Briefly in Figure 2.1 commercial Fe3O4 particles are coated in branched PEI. The

adsorbed PEI creates a positive zeta potential, increasing colloidal stability, and allows
silica coating using TEOS. A modified two step Stöber process encapsulates the Fe3O4
particle.6 Annealing at 1050 oC under vacuum condenses the siloxane bonds, and protects
the Fe3O4 from oxidation. These hermetically sealed particles can now survive the high
acid environment encountered during rehydroxylation and silane addition allowing robust
silane surface chemistry to be applied. Finally, polymerization using SI AGET ATRP
forms the 10 nm thick epoxide capture layer with low biofouling properties.

2.4.3

IR Characterization
Analysis using FT-IR confirmed composition of particles during different stages

of the manufacturing process Figure 2.2. The presence of magnetite can be identified by
the strong absorption band between 800 and 520 cm−1.11 The presence of SiO2 after
reaction and annealing is verified by the Si–O–Si stretching vibration at 1070 -1080 cm−1
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as well in the Fe–O–Si stretching vibration at 1050 -1250 cm−1.12 Polyacrylamide can be
identified due to the N–H stretching modes of amino groups giving split bands between
3300 – 3500 cm-1 and carbonyl groups of the amide pendants at 1690 cm-1.13 The high
intensity peak at 1720 cm-1 is indicative of C=O stretching of esters, and the absorption at
908 cm-1 is related to the epoxy group stretching.16

2.4.4

Magnetic Characterization
Hysteresis loops in Figure 2.3 showed the saturation magnetization of the

Fe3O4@SiO2@polymer particles to be 44 emu/g compared to the starting material
magnetization of Fe3O4 94 emu/g. Conversely BcMag particles have a saturation
magnetization of 32 emu/gram and Dynabeads have a saturation magnetization of 19
emu/g. By increasing magnetization, particle size can be reduced while maintaining a
speedy recovery from solution. One drawback of the larger Fe3O4 particle size used in
this work is that the remnant magnetization causes aggregation during silica coating
which can be seen in the TEM images Figure 2.4.17

2.4.5

Thermal Studies
Due to the high temperatures required for processing the Fe3O4@SiO2 particles

we wanted to understand how the annealing process affects the particles magnetic
properties. The first study conducted was to compare Fe3O4, Fe3O4 annealed,
Fe3O4@SiO2, Fe3O4@SiO2 annealed, and Fe3O4@SiO2@polymer particles saturation
magnetization in Figure 2.5. As expected magnetization decreased in a stepwise fashion
for the conversion of Fe3O4 to Fe3O4@SiO2 to Fe3O4@SiO2@polymer due to the
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increasing mass of nonmagnetic material. However, it is interesting to note that annealing
Fe3O4 alone results in an approximately 35 emu/gram drop from non-annealed Fe3O4.
This is probably due to a small amount of oxygen present in the vacuum oven during
annealing. At such high temperatures, even a small amount of oxygen would oxidize
Fe3O4 to Fe2O3. Particles did have a slight reddish orange color indicative of some
oxidation but no further characterization was performed. One point of interest is that
Fe3O4@SiO2 annealed gained 3 emu/gram over Fe3O4@SiO2. This gain in magnetism is
probably due to the loss of ethanol, water, and ammonia, which happens in Stöber silica
particles as well Figure 2.6.
Large 100 nm Fe3O4 particles are ferrimagnetic at room temperature. However, if
heated above the blocking temperature they will become superparamagnetic, decreasing
interparticle attractions.18 If ferromagnetic Fe3O4 particles could be heated above the
blocking temperature during the silica coating steps, a reduction in aggregation might be
possible. To study this, hysteresis curves at 80 oC were collected. It can be seen from
Figure 2.7 that, although heating the particles did lower the hysteresis it reduced it by an
insignificant amount. Ultimately 80 oC was the hottest temperature chosen for performing
the hysteresis study because performing a twostep Stöber reaction at a temperature higher
than 80 oC would result in having to use special pressurized glassware. This is due to the
boiling points of the solvents used.
During magnetic characterization of intermediates, an increase in remnant
magnetization was noticed and investigate further. Plotting Fe3O4, Fe3O4 annealed,
Fe3O4@SiO2, Fe3O4@SiO2 annealed, and Fe3O4@SiO2@polymer in Figure 2.8 the
hysteresis increases only in particles that have been annealed with a silica shell. Adding a
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coating of silica or polymers has little to no effect on the remnant magnetization but
annealing with a silica shell doubles the hysteresis from approximately 150 Oersted to
300 Oersted. This could be caused by the formation of various iron silicon complexes.19
For this reason we decided to keep the annealing time short as possible.
Even with the relatively fast synthesis of Fe3O4@SiO2 particles multiple steps,
and scale limitations hinder particle production. If Fe3O4@SiO2@polymer particles could
be reused or converted back to Fe3O4@SiO2 a reduction in average synthesis time is
realized. It was found that by placing Fe3O4@SiO2@polymer particles in a laboratory
oven at 400 oC, all surface polymer could be removed. The previously annealed silica
shell protected the Fe3O4 from oxidation due to oxygen due to its impermeability to
oxygen. Particles could then be rehydroxylated and surface modified with polymer. This
simple step eliminated the need for PEI coating, and two Stöber steps shortening the
three-day total synthesis down to two days for recycled particles.

2.4.6

Epoxide Surface Optimization.
The appropriate amount of glycidyl methacrylate is required to build a functional

surface. If too many epoxides are present, proteins can be denatured by multiple covalent
bonds. Too little limits the binding capacity. To determine the optimal capacity SI AGET
ATRP was performed by varying molar ratios of glycidyl methacrylate to acrylamide on
100 nm silica IP particles. Three molar ratios of 2:3, 1:1, and 3:1 were synthesized and
reacted with fluorescent BSA. As expected as epoxide concentration increased so did the
color intensity on the surface of the particles Figure 2.9. IP was also performed using
chicken anti BSA bound to extract fluorescent BSA from solution. In this experiment, the
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1:1 ratio showed the highest intensity with color intensities dropping on the 3:2 and 2:3
ratios respectively. For this reason, the 1:1 ratio was chosen for all other IP experiments.

2.4.7

Binding Capacity
In order to compare all IP particles, capacity in μg of antigen per mg of particles

is reported by measuring the release of antigen after it was bound to active antibodies on
the IP particle. It can be seen from Figure 2.10 that all bead surfaces saturate with
antibody after approximately 4 hours, and the capacity of the Fe3O4@SiO2@polymer
beads is almost two-fold higher than the commercial particles. Although reporting μg of
antigen capacity per mg of particles is helpful, but it does not speak to the overall quality
of the particle surface. Particles with a large surface area to mass ratio are given a
meaningless advantage over particles with a low surface area to mass ratio in regard to
antigen capacity. With this in mind we decided to look at the nonspecific binding of the
IP beads and compare the signal to noise ratio of all IP particles. Figure 2.11 shows that
the reported magnetic particles have an approximate two-fold signal-to-noise
enhancement over Dynabeads and a 12-fold enhancement over BcMag. We believe that
the high signal to nose ratio is made possible by the dense polymer chain morphology
which is not present on Dynabeads or BcMag.
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2.4.8

Antibody Stability
Upon close inspection of TEM images, obvious differences in surface structure

were noticed. It can be seen from Figure 2.12 that Dynabeads and BcMag have similar
surface morphology. Both report having a polystyrene (Dynabead) or silica surface
(BcMag) coated with a short 1.0-nm epoxide linker. The Fe3O4@SiO2@polymer particles
are similar to the BcMag particles, but have considerably longer 10 nm long epoxide
linkers. To see if these differences would have any effect on bound antibody stability,
capacity of each bead was measured. Then antibodies were stressed by overnight
incubation at 35 oC and 3000 RPM agitation. It can be seen from Figure 2.13 that the
reported particles retained the most capacity while the commercial particles lost
considerably more capacity. The polystyrene shell of Dynabeads is an improvement over
the exposed silica on BcMag particles, but the 10-nm thick polymer layer present on the
Fe3O4@SiO2@polymer particles helps shield the bound antibodies from silanols present
on the surface. It also could be that the hydrogen bonding to the polymer layer reduces
damage from shear forces present during the agitation.

2.5

Conclusion
Silica-coated magnetic nanoparticles were prepared using large Fe3O4 particles to

obtain high magnetization even with a thick silica layer, allowing fast extraction with
common N52 neodymium magnets. Silanization of the Fe3O4@SiO2 particles, followed
by AGET ATRP polymerization, permits covalent antibody binding for performing
immunoprecipitations. The structure and composition of the silica coated magnetic
nanoparticles were investigated by using TEM and FT-IR methods, showing an effective
stepwise manufacturing process. Comparison with equivalent commercial beads,
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Fe3O4@SiO2@polymer exhibited an improved specific binding and low nonspecific
binding, reaching higher capacity under the same conditions as commercial IP beads, and
better stability under stressed conditions.
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A

B

Figure 2.1 General synthetic outline (A) cube shaped Fe3O4 (black) is coated in
branched PEI (red) then silica (grey). Surface functionalization (B) is performed using
a typical chromatographic bonded phase protocol with a monochloro silane. AGET
ATRP adds the final low biofouling, high capacity polymer capture layer.
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Figure 2.2 KBr FT-IR spectra of Fe3O4, Fe3O4@SiO2 (annealed) , and
Fe3O4@SiO2@polymer. The spectra are normalized with respect to the absorbance at
1099 cm-1.
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A

B

Figure 2.3 Hysteresis curves of the Fe3O4@SiO2@polymer vs. BcMag vs.Dynabead.
Please note the 10x difference in x axis scale between (A) and (B).
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A

B

C

Figure 2.4 TEM images of (A) Fe3O4 starting material, (B) Fe3O4@SiO2 after soaking in
37% HCl for 12 hours (C) Annealed Fe3O4@SiO2 after soaking in 37% HCl for 12 hours.
(D) Final Fe3O4@SiO2@polymer particle
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Figure 2.5 Magnetic saturation at various processing steps.
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Figure 2.6 350 nm silica particles before and after annealing at 1050 oC. The loss of
ammonia, water, and ethanol drastically reduce the relative peak height between 3700
and 2750 cm-1.
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Figure 2.7 Hysteresis comparison of Fe3O4 at 27 oC and 80 oC.
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Figure 2.8 Hysteresis comparison of magnetic particles at various stages of manufacture.
Note the increase in hysteresis of annealed silica particles.
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Figure 2.9 (A) represents the particles bound with BSA only. (B) particles
with BSA bound via antibody antigen interaction.
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Figure 2.10 Anti-BSA binding kinetics and particle capacity probed with fluorescent
BSA. Anti-BSA, and BSA concentrations were 0.1 mg/ml in PBS.
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Figure 2.11 Signal to noise ratio for each of the studied IP particles.
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Figure 2.12 Close up TEM images of (A) Fe3O4@SiO2@polymer, (B) BcMag, and (C)
Dynabead.

45

Figure 2.13 Fe3O4@SiO2@polymer particles retained the most antibody activity after
being stressed.
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CHAPTER 3.

3.1

DNA CHROMATOGRAPHY USING TALE
PROTEINS

Abstract
Transcription activator like effectors (TALE) were coupled to 2.0 um silica

particles and packed into a capillary column. KCl was used to modulate the binding
affinities of the TALE DNA complex for optimized separation of target and off target
DNA sequences. Fluorescence on column detection allowed DNA stacking
characteristics to be analyzed, which matched reported TALE DNA release kinetics.
Isocratic separation yielded the best balance of retention and separation but did not fully
resolve the two strands.

3.2

Introduction
Xanthomonas bacteria modify protein expression in host plat cells to increase

infection rates1 This is accomplished with TALE proteins. TALE proteins have a coil like
structure which allows sequence specific binding in the major DNA grove. A crystal
structure show in Figure 3.1 describes the arrangement.2 The beauty of TALE proteins is
the ease in which they can be programmed for a specific DNA sequence. Modification of
residues 13 and 14 set the sequence specificity while the number of central repeat
domains determine the number of base pairs interrogated.3–6 By reprogramming TALE
scientists have been able to edit plant genomes, or quickly confirm the existence of a
specific DNA sequence.7,8 Due to TALE’s sequence specificity, we wondered if TALE
proteins could be used to purify a specific gene from cell lysate. If possible, all histones
or DNA binding proteins associate with the gene could be analyzed. This technique
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would be like engineered DNA-binding molecule-mediated chromatin
immunoprecipitation without the need to transfect the cells of interest.9

3.3

3.3.1

Experimental

Materials
Silica particles were purchased from Superior Silica. House deionized water was

purified using a Milli-Q Gradient system to a final resistivity of 18.2 mΩ.
((Chloromethyl)phenylethyl dimethyl)lchlorosilane (98%) was purchased from Gelest.
Silica gel (60 Å) was ordered from Sorbtech. Bovine serum album (BSA, Alexa Fluor®
555 conjugate) BSA antibody (Anti-BSA, 70-BC67, Fitzgerald). CuCl2 (99.995%) tris(2dimethylaminoethyl)amine (Me6Tren, 97%), acrylamide (99%), glycidyl methacrylate
(97%), 2-Amino-2-hydroxymethyl-1,3-propanediol (tris, 99.9%), potassium chloride
(KCl, 99%), and nitric acid (68%), were procured from Sigma Aldrich. T-20 non-protein
blocking buffer, and toluene (99.5%) were purchased from Thermo Fisher Scientific. 2.0
µm stainless mesh was purchased from TWP Inc. 100 µm I.D. 360 O.D. TSH capillaries
were purchased from Polymicro Technologies.

3.3.2 Thermal Treatments
Nonporous silica particles 2.0 µm, and 100 nm were placed in a Lindberg Blue
furnace, heated to 600 oC for 6 hours and allowed to cool. Particles were sonicated into a
2% suspension with water, centrifuged, and dried. This process was repeated two more
times. A fourth heating was conducted at 1050 oC for 1 hour. After cooling, the particles
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were suspended in water via sonication and filtered through a 2 µm stainless steel mesh
to remove aggregates.

3.3.3 Silica Modification
The filtered suspension was acidified with nitric acid to 1.0 M, refluxed 24 hours,
washed three times via centrifugation, and dried under vacuum. 2.0 g were suspended in
150 ml of dry toluene via sonication. 1.5 ml of ((chloromethyl)phenylethyl
dimethyl)lchlorosilane, and 150 µl of ethanol amine were added to the milky suspension,
which was refluxed three hours. Particles were collected via centrifugation, washed three
times with toluene, and dried at 60 oC.

3.3.4 Polymer Grafting of Epoxide Surfaces
Nitrogen sparging for 30 min. was used to deoxygenate all solvents. 14.1 mg of
CuCl2 (0.105 mmol), 17.5 ml methanol, 28.1 μl Me6Tren (0.105 mmol), 947 mg
acrylamide (13.3 mmol), and 50 mg of initiator modified nanoparticles from 3.3.3 were
sonicated into solution under sparging. Upon suspension 17.5 ml water, and 3.4 mg
sodium ascorbate (0.017 mmol) were added. After 5 min 2000 μl glycidyl methacrylate
(14.6 mmol), and 10.4 mg sodium ascorbate (0.0525 mmol) was added, and sparging was
continued for 5 min. Upon completion, particles were centrifuged, washed three times
with water, and vacuum dried overnight.
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3.3.5 TALE Construction
TALE proteins and fluorescently labeled DNA strands were graciously provided
by Dr. Yuan’s lab at Purdue. Special thanks to Agnes, and Oscar for help troubleshooting
experiments and generating the TALE protein used in these experiments.

3.3.6 TALE Binding
5.0 mg of epoxide coated silica particles are suspended in PBS at 20 mg/ml via
sonication. 20 µl is removed and placed in a small vial with 50 µl of .1 mg/ml
fluorescently labeled BSA 555. 20 µl of 0.5 mg/ml TALE protein is added to the original
vial. Both vials are allowed to shake at 1000 rpm for 1 hour. Upon completion, the vial
containing BSA is rinsed two times with 0.5% SDS solution, and once with water. If the
particles are red in color, (indicating an active epoxide surface) the assay is continued.

3.3.7 Capillary Packing
A 15-cm length of capillary is cut and filled with slurry from the vial containing
the silica particles bound with TALE protein. A frit is added and the capillary connected
to the HPLC. The slurry is packed at 1000 psi using a 0.25 M KCl, 20 mM tris buffer at
pH 7.5.

3.3.8 DNA Separation Conditions
Mobile phase A contained 20 mM tris buffer at pH 7.5, mobile phase B contained
20 mM tris buffer at pH 7.5 and 0.5 M KCl. Separations were performed under isocratic
conditions utilizing a 0.15 M KCl salt concentration. Figure 3.2 shows the separation
setup. TALE-DNA extractions were performed using a low salt capture buffer of 20 mM
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KCl and 20 mM tris buffer at pH 7.5. DNA elution was accomplished using a two-step
salt gradient of 0.5, and 1.0 M KCl.

3.4

Results and Discussion

3.4.1 DNA Extraction
In order to determine the selectivity of TALE protein to target and off target DNA
sequences 100 nm SiO2@polymer particles were bound with TALE selective for the 157
bp Widom 601 DNA sequence. Nanoparticles conjugated with TALE were suspended in
a mixture of TALE:Widom 601:MMTV at a ratio of 1:1:1. As a control TALE:MMTV
DNA was made mixed a ratio of 1:1. MMTV has no sequence recognized by the TALE
protein. DNA concentration was 0.1 µM. Upon mixing the TALE:DNA complexes were
allowed to equilibrate for 30 min under agitation. After equilibrium was reached the IP
particles were washed three times with a low salt capture buffer. The low salt wash
removes any nonspecifically bound DNA. DNA was released using a two-step salt
extraction. Each of the supernatants were separated using gel electrophoresis. Figure 3.3
shows the corresponding DNA gel in which TALE shows a similar affinity for Windom
601 and MMTV. Considering the mild conditions DNA extraction using TALE protein
could never attain the level of selectivity required to purify one gene from a cell extract
even if the protocol was optimized further.

3.4.2 DNA Chromatography
To improve DNA selectivity other DNA binding proteins could be used. Zinc
fingers offer increased selectivity. However, the ease in which the TALE system can be
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modified is unparalleled making switching to zinc fingers cumbersome.10 Physical
purification techniques such as affinity chromatography have been used to produce high
purity antigens and was investigated for use in TALE/DNA chromatography.11,12 To this
end a 100 µm capillary column was packed using 2.0 µm silica particles with a TALE
stationary phase manufactured similarly to the 100 nm extraction particles.
Initial low salt isocratic separations showed DNA stacking at the head of the
capillary but immediately DNA began to slowly move down the capillary in a broad
tailing peak. Figure 3.4 shows that even under retaining conditions peak stacking is
relatively poor as the DNA is eluted after 60 seconds. Increasing ionic strength to 0.15 M
KCl under isocratic conditions improved resolution dramatically. Figure 3.5 shows the
optimized separation of target and off target DNA using a mixture of 4.0 femtomoles
TAMRA labeled Widom 601, and 4.0 femtomoles FAM labeled MMTV at the end of 3.0
cm. Gradient elution from 30 mM KCl to 200 mM at 30 mM per min. was also tried but
did not yield any appreciable separation.
These results are not surprising when literature reports of TALE binding kinetics
were reviewed. TALE DNA binding events follow an exponential decay but, the longest
event recorded under low salt conditions is 60 seconds. The majority of binding events
last 10 seconds or less limiting the common practice of injection peak stacking to
seconds.13 Poor stacking also eliminates gradient elution leaving isocratic conditions as
the only viable option.
TALE capillary columns exhibited extremely short lifetimes. In many cases
performance was degraded after one separation Such short lifetimes were surprising as
the epoxide acrylamide surface had the highest activity of bound antibodies under
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stressed conditions when compared against commercial epoxide particles Figure 2.12.
Currently the mechanism of degradation is unknown but shear forces could explain the
trend as shear would be much higher in the column format as compared to suspended
immunoprecipitation particles.

3.5

Conclusion
Employing capillary chromatography, two different DNA strands were separated.

Column lifetime was extremely short as TALE surface activity rapidly decreased from
run to run. Column degradation is not currently understood but high shear force is
thought to be the culprit.
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Figure 3.1 TALE (blue) bound to DNA (green). Image generated from a crystal structure
in PyMOL.
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D
Figure 3.2 Separation setup for capillary column using fluorescence detection. (A) inlet
from pump leading to (B) the set of three-way valves (C) Sample injection capillary (D)
capillary column.

57

A

A

B

C

D

E

F

G

H

I

J

Figure 3.3 DNA gel of extraction experiment. (A) 100 base pair increment DNA
ladder. The lowest band is 100 base pairs (B) last low salt wash of TALE: Widom
601 (C) Last low salt wash of TALE:Widom 601:MMTV (D) last salt wash of
blocked IP particles mixed with both MMTV and Widom 601. (E) TALE: Widom
601 0.5 M KCl release (F) TALE:Widom 601:MMTV 0.5 M KCl release. (G)
TALE: Widom 601 1.0 M KCl release (H) TALE:Widom 601:MMTV 1.0 M KCl
release. (I,J) no sample loaded. NOTE: Widom 601 is the high band (157 base pairs)
MMTV is the lower band at 147 base pairs.
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A

B

C

Figure 3.4 Florescence images showing the poor stacking of DNA on TALE capillary
columns. (A) Before injection, (B) during injection, and (C) is 60 seconds after injection.
As you can see the majority of the fluorescent DNA has been washed away. Flow is from
right to left. The scale bar is 100 µm.
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A
B

Figure 3.5 Viewing the same capillary under two different fluorescent filters allows (A)
FAM labeled MMTV (off target DNA) to be distinguished from TAMRA labeled Widom
601 (target DNA). Please note that the MMTV DNA sequence is less retained than the
Widom 601 sequence as expected. Scale bar is 100 µm. Flow is from left to right.
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CHAPTER 4.

4.1

FUTURE DIRECTIONS

Magnetic Trapping for Precious Sample Analysis
Magnetic particles have opened new avenues of sample preparation with techniques

such as AirJump.1 Sadly, these technique have had little impact on instrument sample
handling systems. Which in some cases can be a major source of analyte loss.2 Magnetic
sample handling systems have the potential to address this issue by reducing the number
of sample transfer steps.
In the case of immunoprecipitation magnetic manipulation would allow the antigen
release step to be performed inside an HPLC sample injection loop Figure 4.1. By doing
this higher sample recovery rates may be achieved as the extra vial transfer steps are
eliminated. This type of injection system would also allow smaller samples to be analyze.
In the case of HPLC sample analysis is limited by the liquid height in the vial. If the total
sample does not have enough volume to reach the sample needle the sample cannot be
analyzed. If instead the sample is directly released from the magnetic beads inside the
instrument injection loop no sample to vial loss can occur. Automation of these systems
should be relatively easy. Small electromagnets could allow precise trapping of particles
in the injection loop while common HPLC solvents can disrupt the antigen antibody
interaction.3 Even in cases such as hydrophobic interaction chromatography antibody
antigen interactions could be broken and stacked under the high salt conditions.

4.2

Improving Magnetic Nanoparticles Characteristics
Fe3O4 is commonly used in magnetic particles. The low cost of starting materials,

and easy synthesis procedure make Fe3O4 ideal for large scale production. However,
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Fe3O4 has a maximum saturation magnetization of approximately 100 emu/gram.
Designing particles with materials such as FeCo (245 emu/gram) would allow much
higher magnetization values to be attained.4 These extremely high magnetization values
would improve extraction efficiencies, allow smaller particle sizes for greater preconcentration of the extracted sample. It would also lower detection limits in magnetic
sensing platforms.5
Generally, ferrimagnetic nanoparticles aggregate due to the remnant magnetization.
Granger et. al. found that polyelectrolyte layers could be used to reduce aggregation of
100 nm Fe3O4 cubes, but the synthesis is time consuming.6 Lee et. al. found that
increasing particle size lead to a decrease in aggregation.4 It is hypothesized that this
occurs due to the fact that as particle size increases so does the number of magnetic
domains causing particle coercivity to decrease.7,8 Other coating methods such as atomic
layer deposition have shown promise singly coating ferrimagnetic nanoparticles.9
Although expensive, this gas phase technique would eliminate the two silica coating steps
and may eliminate the thermal annealing step. If SiO2 could be deposited instead of
Al2O3, atomic layer deposition would provide a viable option for generating robust singly
coated magnetic core particles with a high surface area.

4.3

Improving DNA Column Lifetime
DNA chromatography as discussed in chapter three suffered from short column

lifetimes. This is probably due to TALE’s instability under shear. Therefore, replacing
the TALE protein with a more robust DNA selective surface may be the best option.
Short peptides have shown some success selectively extracting DNA with binding
constants in the nanomolar range. However, targeting sequences longer than six base
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pairs has not been demonstrated.10 If longer sequences could be efficiently targeted DNA
binding oligomers could provide the overall selectivity and robustness necessary to purify
complex DNA samples.

4.4

Direct MALDI Analysis of Analytes Bound to Magnetic Particles
Immunoassays generally incorporate an antigen release step at the end of the assay,

allowing the extract to be interrogated using characterization methods such as mass
spectrometry or HPLC. It also causes sample loss due to issues with vial transfer, as
discussed earlier. If antigens could be analyzed directly on the surface of the
immunoprecipitation particles sample transfer, and sample loss would be reduced.
Previous Wirth group members have shown acrylamide coated silica particles can
be used in place of a standard stainless steel MALDI plate.11 The detection limit of
MALDI is directly related to how much laser energy is absorbed on the surface to
generate ions.12 In the case of Fe3O4@SiO2@polymer particles they are similar to
SiO2@acrylamide but should adsorb much more laser energy due to the Fe3O4
component. Surface polymer chemistry could also be modified with different monomers
depending on the wavelength of laser used.

4.5

2D Separations using Colloidal Crystals
2D separations are an excellent way to increase resolving power. If two orthogonal

separation methods are used then peak capacity is the product of the first dimensions
peak capacity multiplied by the second dimensions peak capacity. However, taking full
advantage of this phenomena is difficult. If the cycle type of the second dimension is not
fast enough a reduction in peak capacity is observed.9 Various tricks have been employed
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to get around the timing issue, such as continuous separation in the second dimention.10
In the case of 2D gel electrophoresis a simpler method is used. Peaks from the isoelectric
focusing (first dimension) are physically transferred to the size exclusion gel (second
dimension). This allows the first dimension to run to completion, and then the second
dimension to process the entire first dimension in one run eliminating the need for a fast
cycle time on the second dimension as all peaks are processed in parallel.
True 2D separations have yet to be realized in the microfluidic format as no
methods have been developed to transfer all peaks from the first dimension to the second
dimension in parallel. However, using colloidal crystals and florous ferrofluid liquid
handling, a true 2D high resolution separation may be attainable.11,12 A diagram of the
proposed device setup is show in Figure 4.2. In order to fabricate the device with a gap
for the ferrofluid, the ferrofluid should be held in place while the colloidal crystal is
grown.
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A
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C
Figure 4.1(A) Magnetic particles bound with fluorescently labeled BSA are
concentrated in a 100 um ID capillary. (B) After denaturing with heat
fluorescent BSA is released and stacked at the head of a C18 capillary column
under aqueous conditions. BSA is imaged using an inverted fluorescence
microscope. Flow direction is towards the bottom of the page. (C) N52 magnet
used to trap and hold magnetic particles.
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Figure 4.2 Proposed 2D electrophoresis chip design. Orange is the florous ferrofluid
which separates the isoelectric focusing portion (green) from the electrophoresis portion
(yellow). The white and black dots represent the silica colloidal crystal in which the
separation would occur.
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Abstract: Magnetic beads are widely used for high-throughput immunoprecipitation. The
most widely used magnetic beads, e.g., Dynabeads, are 2.7 µm polystyrene spheres
embedded with superparamagnetic Fe3O4 nanoparticles. Epoxide functional groups at the
polystyrene surface allow binding of antibodies. The idea tested in this work is whether
using larger ferromagnetic Fe3O4 particles, protected by a nanoscale silica shell, i.e.,
Fe3O4@SiO2, would give stronger magnetism and higher binding capacity. To this end,
silica shells were formed on Fe3O4 nanoparticles by the Stöber process. Vacuum
annealing at 1050 oC was found to make the shells impervious to a 12-h exposure of
concentrated HCl. Imaging by TEM revealed that the annealed shells were 50 nm in
thickness. TEM also showed that the nanoparticles agglomerated into nearly micrometer
sized aggregates, albeit with high surface area. For functionalizing the shell surface, a 10
nm polymer layer was grafted to a silane initiator on the silica surface by activator
generated electron transfer atom transfer radical polymerization (AGET ATRP). The
polymer layer was a block copolymer of polyacrylamide, to minimize protein adsorption,
and glycidyl methacrylate, to covalently attach antibodies. The resulting
Fe3O4@SiO2@polymer particles easily dispersed in aqueous solution. The particles were
determined by a superconducting quantum interference device (SQUID) to be
approximately three times more magnetic than Dynabeads. The binding capacity,
determined by immunoprecipitation, showed that the Fe3O4@SiO2@polymer particles
have twice binding capacity as the Dynabeads while retaining low nonspecific binding.
Introduction
Immunoprecipitation (IP) is a ubiquitous purification method for extracting proteins from
complex media such as cell lysate or serum. In general, a solid support decorated with
antibody is released into a complex sample where the antibody selectively binds the
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target. The support bound complex can then be retrieved via filtration, flotation, or
magnetic field gradient.1-3
Recent techniques such as AirJump have shown magnetic extraction techniques to
be superior when compared to conventional extraction techniques. Specifically, these
techniques have demonstrated increased recovery, decreased background, and high
throughput capability.4 However, these techniques can only be performed with magnetic
particles, which highlights the inherent benefits of improving them.5-7
Silica coating of Fe3O4 is commonly performed to enhancing particle stability and
increase surface functionality.8 Although the magnetic core is completely coated in silica
common reactions involving high temperature and/or hydrochloric acid can still lead to
loss of the metal oxide center.9, 10 This is due to the microporous nature of silica produced
using the Stober method.11, 12
One issue with Fe3O4@SiO2 type particles is that the silica shell can greatly
reduce magnetism. To mitigate this issue, high magnetization materials and larger core
particles can be used to produce high-moment particles.13 Currently Fe3O4@SiO2
particles cannot take full advantage of the silica coating, due to the porous nature of
silica. Generating dense surface coverage of silanes is difficult as it requires refluxing
silica in concentrated nitric acid. Surface modification using chlorosilanes is also
detrimental to the magnetic core due to the generation of hydrochloric acid upon silane
attachment to the silica surface. We have previously discovered both of these steps are
necessary to the generate densely modified surfaces necessary for low biofouling.14, 15
Adding a copolymer, such as glycidyl methacrylate, allows biomolecules to be bound to
the surface while retaining the surface’s low fouling properties.16, 17
In this study, Fe3O4@SiO2 particles were synthesized and annealed at high
temperature under vacuum conditions. The now acid stable particles could survive
rigorous rehydroxylation with nitric acid and the hydrochloric acid generated during the
silane addition. Further surface modification using AGET ATRP allowed an
approximately 10 nm thick block copolymer film to be grown, which allowed for the
capture of antibodies. Overall higher magnetization, and lower biofouling was realized
over commercial, silica and polystyrene epoxy coated, immunoprecipitation beads.
Experimental section
Materials
House deionized water was purified using a Milli-Q Gradient system to a final resistivity
of 18.2 mΩ. 50-100 nm Fe3O4 nanoparticles were purchased from Nanostructured &
Amorphous Materials, Inc. 200 proof ethanol was acquired from Decon Laboratories.
Branched polyethylenimine (PEI, Mw ∼ 25,000 Mn 10,000), tetraethyl orthosilicate
(TEOS, 97%) CuCl2 (99.995%) tris(2-dimethylaminoethyl)amine (Me6Tren, 97%)
acrylamide (99%), glycidyl methacrylate (97%), 2-Amino-2-(hydroxymethyl)-1,3propanediol (tris, 99.9%), phosphate buffered saline (tablet) were procured from Sigma
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Aldrich. Chloromethyl phenylethyl dimethylchlorosilane (98%) was purchased from
Gelest. Silica gel (60 Å) was ordered from Sorbtech. Bovine serum albumin (BSA, Alexa
Fluor® 555 or 488 conjugate) BSA antibody (Anti-BSA, 70-BC67, Fitzgerald).
Dynabeads M-270 epoxide, T-20 non protein blocking buffer, toluene (99.5%), (Thermo
Fisher Scientific). BcMag epoxide (Bioclone inc.).
Silica coating
A 5.0 mg/mL dispersion of Fe3O4 in ethanol was sonicated (Branson 3800) for 3 hours.
Upon completion, the dispersion was magnetically extracted, and dried at 60 oC under
vacuum. 500 mg of the dried material was added to 100 mL of aqueous solution
containing 1% w/v PEI. This mixture was sonicated for 8 hours, and collected via
centrifugation. 250 mg of the PEI coated Fe3O4 was placed in 250 mL of water and
sonicated for 10 min. Next, 10 mL of TEOS and100 mL of ethanol were added, and
sonicated for 1 hour. The particles were magnetically extracted, washed three times with
ethanol, and dried at 60oC. 110 mg of the silica coated Fe3O4 was sonicated for 10 min in
a solution of 400 mL of ethanol and 80 mL of water. 8.3 mL of NH4OH and 1 mL of
TEOS was added. Sonication was continued for 1 hour. Finally the particles were
magnetically extracted and dried.
Thermal treatments
The silica coated Fe3O4 was placed in a vacuum oven, heated to 1050 oC at a rate of 8
o
C/min., held at this temperature for 10 min, and allowed to cool at 15 oC/min.
Addition of AGET ATRP Initiator
500 mg of silica coated Fe3O4 was placed in 10 mL of 37% hydrochloric acid for 1 hour
and washed until a neutral pH is reached. Upon completion, 250 mL of 1.0 M HNO3 is
added and the particles were refluxed 24 hours. Particles were washed 5 times with water
and dried under a vacuum. 500 mg of particles were placed in 100 mL of dried toluene,
and sonicated into suspension under a nitrogen blanket. 2.0 mL of chloromethyl
phenylethyl dimethylchlorosilane was added along with 100 μL of ethyl amine. The
reaction was refluxed for 3 hours. Upon completion, the particles were washed thrice
with toluene and dried at 60oC.
Polymer grafting
All solvents were deoxygenated via nitrogen sparging for 30 min. In a 50 mL centrifuge
tube, 14.1 mg of CuCl2 (0.105 mmol), 17.5 mL of methanol, 28.1 μL of Me6Tren (0.105
mmol), 947 mg of acrylamide (13.3 mmol), and 50 mg of initiator modified nanoparticles
were sonicated into solution under sparging. Upon suspension, 17.5 mL of water, and 3.4
mg of sodium ascorbate (0.017 mmol) were added. After 5 min, 2000 μL of glycidyl
methacrylate (14.6 mmol), and 10.4 mg of sodium ascorbate (0.0525 mmol) were added,
and sparging continued for 5 min. Upon completion, the black particles were
magnetically extracted, washed thrice with water, and vacuum dried overnight.
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Antibody capacity
5 mg/mL of epoxide coated particles were allowed to react with, 0.1 mg/mL of Anti-BSA
in PBS. Samples were placed on a shaker plate at 750 rpm and allowed to react for a
specified time. Upon completion, a 50 μL aliquot was removed and diluted with 400 μL
of T-20 blocking buffer to stop the antibody binding. The vials were then agitated for 1
hour. Blocked beads were washed thrice with 1x PBS and agitated in 100 μL of 0.1
mg/mL fluorescently labeled BSA/PBS solution for 1 hour. Particles were washed thrice
with 20mM tris buffer at pH 8.2 and suspended in 20 μL of 2% SDS for 30 min. The
supernatant was removed and placed in a cuvette with tris buffer.
Nonspecific binding
Approximately 3 mg of beads were suspended in 600 μL of T-20 blocking buffer and
allowed to react for 1 hour. Next, the beads were washed thrice with PBS and placed in
100 μL of 40 mg/mL fluorescent BSA/PBS solution. After agitation for 1 hour, particles
were washed six times, vials were changed and washed four more times with 20 mM tris
buffer. Release and analysis conditions were the same as previously described.
Recovery
1.0 μg of respective antigen bead capacity was added to a suspension of 50 μL of PBS
buffer with with 0.5 μg of labeled BSA for 1 hour. Particles were washed thrice with tris
buffer. Release and analysis conditions were the same as previously described.
Magnetic characterization
Approximately 5 mg of material was loaded into a SQUID straw, and a four quadrant
scan is performed using an MPMS-3 at 300 K. An identical scan using a gadolinium
gallium garnet was used to correct for the residual magnetic moment of the instruments at
zero magnetic field.
Infrared analysis
Dried KBr was added to the tested samples to obtain a 0.3 % mixture. After grinding it to
fine powder in an agate mortar, approximately 80 mg of the mixture was pelletized in a
hydraulic press. IR spectra were collected using an FT-IR spectrometer (Tensor 37,
Bruker Optik GMBH).
Results and Discussion
Figure 1.0 illustrates the process of coating commercial Fe3O4 particles. First, they are
coated in PEI, which creates a positive zeta potential, increases colloidal stability, and
allows for silica coating. A modified two step Stöber process encapsulates the Fe3O4
particle in a silica layer.13 Annealing at 1050 oC condenses the siloxane bonds, and
vacuum conditions prevents the Fe3O4 from oxidizing. These hermetically sealed
particles are impervious to the high acid environment encountered during rehydroxylation and silane addition, and allows robust, silane surface chemistry to be
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applied. The silanes used have terminal groups that are active for AGET-ATRP synthesis,
which forms the 10 nm thick epoxide capture layer with low biofouling properties.
Analysis using FT-IR confirmed composition of particles during different stages
of the manufacturing process. Figure 2 shows the FT-IR spectra of various intermediates.
The presence of magnetite can be identified by the strong absorption band between 800
and 520 cm−1.18 The presence of SiO2 after the annealing is confirmed by the Si–O–Si
stretching vibration at 1070 -1080 cm−1 as well in the Fe–O–Si stretching vibration at
1050 -1250 cm−1.19 Polyacrylamide can be identified due to the N–H stretching modes of
amino groups giving split bands between 3300 – 3500 cm-1 and carbonyl groups of the
amide pendants at 1690 cm-1.20 The high intensity peak at 1720 cm-1 is indicative of C=O
stretching of esters, and the absorption at 908 cm-1 is due to the epoxy group stretching.21
Hysteresis loops in Figure 3 illustrates the final magnetization of the particles to
be 44 emu/g compared to the Fe3O4 starting material magnetization of 94 emu/g.
Conversely, BcMag and Dynabeads have a saturation magnetizations of 32 emu/gram
and 19 emu/g, respectively. The increased magnetization of the particles in this work
allows for reduced particle size while maintaining quick recovery from solution.
However, a drawback of the larger Fe3O4 particle size is that remnant magnetization
causes aggregation during silica coating which can be seen in Figure 4.22 Recently,
Granger et al. has developed a procedure to singly coat nanocubes that are approximately
100 nm in size; however, their method requires considerably more synthesis time.13
To test the performance of the IP particles, capacity in μg of antigen per mg of
particles was used as an initial figure of merit. This was determined by measuring the
release of antigen after it was bound to active antibodies on the IP particle. Figure 5
illustrates that all bead surfaces saturate with antibody after approximately 4 hours, but
the capacity of the reported beads is almost two-fold higher than both types of
commercial particles. Although the μg of antigen capacity per mg of particles is a
valuable figure of merit, it does not speak to the overall quality of the particle surface.
Particles with a large surface area to mass ratio have an intrinsic advantage over particles
with a low surface area to mass ratio in regards to antigen capacity. With this in mind we
decided to investigate the nonspecific binding of the IP beads and compare the signal to
noise ratio of all IP particles. As shown in Figure 6, the reported magnetic particles have
approximately a two fold signal enhancement over Dynabeads and a 13 fold enhancement
over BcMag. We hypothesize the high signal to noise ratio is made possible by the dense
chain morphology which is not present on Dynabeads or BcMag.
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Upon close inspection of TEM images, we noticed obvious differences in surface
structure. Figure 7 shows that Dynabeads and BcMag have similar surface morphology,
but report having a polystyrene or silica surface coated with a ~ 1 nm epoxide linker. The
reported particles are similar to the BcMag particles but have 10 nm long epoxide linkers.
We wondered if these differences would have any effect on bound antibody stability. To
determine this, we measured the capacity of each bead then stressed the antibodies by
incubation overnight at 30 oC and 3000 RPM agitation. Figure 8 illustrates the reported
particles retained the most capacity while the commercial particles lost considerably
more capacity. We hypothesize the polystyrene shell of Dynabeads is an improvement
over the exposed silica on BcMag particles, but the 10 nm thick polymer layer present on
the reported particles helps shield the bound antibodies from silanols present on the
surface and reduces shear forces due to the high speed agitation.
Conclusion
Silica-coated, magnetic nanoparticles were prepared using large Fe3O4 particles to obtain
high magnetization despite the thick silica layer, allowing the fast extraction with
common neodymium magnets. Silanization of the Fe3O4@SiO2 particles, followed by
AGET-ATRP polymerization, permits covalent antibody binding for
immunoprecipitations. The structure and composition of the silica-coated magnetic
nanoparticles were investigated by using TEM and FT-IR, which showed an effective
stepwise manufacturing process. Compared with some commercial beads, SCMN
exhibited improved specific binding, lower nonspecific binding, reaching higher capacity
in short time, and better stability under stress conditions.
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Figure 1 General synthetic outline (A) cube shaped Fe3O4 (black) is coated in branched
PEI (red) then silica (grey). Surface functionalization (B) is performed using a typical
chromatographic bonded phase protocol with a monochloro silane. AGET ATRP adds
the final low biofouling, high capacity polymer capture layer.
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Figure 2 KBr FT-IR spectra of Fe3O4, Fe3O4@SiO2 (annealed) , and
Fe3O4@SiO2@polymer. The spectra are normalized with respect to the absorbance at
1099 cm-1.
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Figure 3 Hysteresis curves of the Fe3O4@SiO2@polymer vs. BcMag, and Dynabead.
Please note the 10x difference in x axis scale between (A) and (B).
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Figure 4 TEM images of (A) Fe3O4 starting material, (B) Fe3O4@SiO2 after soaking in
37% HCl for 12 hours, (C) Annealed Fe3O4@SiO2 after soaking in 37% HCl for 12
hours. (D) Final Fe3O4@SiO2@polymer particle
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Figure 5 Anti-BSA binding kinetics and particle capacity probed with fluorescent BSA.
Anti-BSA, and BSA concentrations were 0.1 mg/ml in PBS.
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Figure 6 Signal to noise ratio for each of the studied IP particles.
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Figure 7 Close up TEM images of (A) Fe3O4@SiO2@polymer, (B) BcMag, and (C)
Dynabead.
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Figure 8 Fe3O4@SiO2@polymer particles retained the most antibody activity after being
stressed.

